Cargando…

Why 2 Studies That Used the Same Probiotic May Have Come Up With Different Outcomes

Detalles Bibliográficos
Autores principales:	McFarland, Lynne V, Kullar, Ravina, Maziade, Pierre-Jean, Goldstein, Ellie J C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906753/ https://www.ncbi.nlm.nih.gov/pubmed/34245249 http://dx.doi.org/10.1093/cid/ciab618

Ejemplares similares

Why Do ACG and AGA Guidelines Differ for the Use of Probiotics and the Prevention of CDI?
por: McFarland, Lynne V., et al.
Publicado: (2022)

Lactobacillus Bacteremia and Probiotics: A Review
por: Kullar, Ravina, et al.
Publicado: (2023)

Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use
por: Kullar, Ravina, et al.
Publicado: (2021)

Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of Clostridioides difficile Infections
por: McFarland, Lynne V., et al.
Publicado: (2023)

Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis
por: McFarland, Lynne V., et al.
Publicado: (2018)

Choosing an appropriate probiotic product for your patient: An evidence-based practical guide
por: Sniffen, Jason C., et al.
Publicado: (2018)

Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy
por: Maziade, Pierre-Jean, et al.
Publicado: (2021)

An observation on inappropriate probiotic subgroup classifications in the meta-analysis by Lau and Chamberlain
por: McFarland, Lynne V
Publicado: (2016)

Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review
por: McFarland, Lynne V.
Publicado: (2015)

Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review
por: McFarland, Lynne V
Publicado: (2014)

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
por: Kullar, Ravina, et al.
Publicado: (2020)

Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach
por: Kullar, Ravina, et al.
Publicado: (2022)

Caution is needed when assessing results of home birth
por: Verd, Sergio, et al.
Publicado: (2019)

The Same
Publicado: (1880)

The Same
Publicado: (1883)

The Same
por: Brown, E. B.
Publicado: (1878)

Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis
por: McFarland, Lynne V., et al.
Publicado: (2021)

Benzodiazepines consumption may have increased during the COVID-19 pandemic
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

An idea whose time has come
por: Banci, Lucia, et al.
Publicado: (2007)

What comes next in the COVID-19 pandemic?
por: Fisher, Dale, et al.
Publicado: (2022)

Why Does Labor Come On?
Publicado: (1881)

Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran
por: Salari, Mehri, et al.
Publicado: (2021)

Pooling data on different probiotics is not appropriate to assess the efficacy of probiotics
por: Szajewska, Hania
Publicado: (2014)

Fronts of Internal Emergency Medicine Research for Years to Come
por: He, Xiao-Jun, et al.
Publicado: (2015)

Should Preachers Pay?: A Daniel Comes to Judgment
por: Kirwan,
Publicado: (1887)

THE1B may have no role in human pregnancy due to ZNF430-mediated silencing
por: Zuo, Zheng
Publicado: (2023)

Why epigenetics is (not) a biosocial science and why that matters
por: Chiapperino, Luca, et al.
Publicado: (2022)

Experimental Acute Lung Injury in Animals: With Age Comes Knowledge
por: Schouten, Laura R., et al.
Publicado: (2022)

Why an even bigger bang is coming
Publicado: (2008)

2417. Feasibility and Safety of Using a Probiotic Comprised of Lactobacillus acidophilus CL1285, L. casei LBC80R and L. rhamnosus CLR2 for C. difficile Infection Prevention Among Antibiotic Users: 15-Years of Prospective Results from a Single-Center
por: Maziade, Pierre-Jean, et al.
Publicado: (2019)

Changing time for acute stroke management: What comes after dawn?
por: Alamri, Yassar
Publicado: (2019)

Reply: Experimental Acute Lung Injury in Animals: With Age Comes Knowledge
por: Kulkarni, Hrishikesh S., et al.
Publicado: (2022)

Probiotics, prebiotics, synbiotics and naturally fermented foods: why more may be more
por: Ho, Nancy, et al.
Publicado: (2013)

Same-visit HIV testing in Trinidad and Tobago
por: Duke, Violet, et al.
Publicado: (2010)

Why Not Clean Milk?
Publicado: (1923)

Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
por: Aguirre, Clara, et al.
Publicado: (2020)

Podocyturia: why it may have added value in rare diseases
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2018)

An analysis of online messages about probiotics
por: Brinich, Margaret A, et al.
Publicado: (2013)

Psychobiotics: An emerging probiotic in psychiatric practice
por: Kali, Arunava
Publicado: (2016)

Why Are We One-Sided?
por: Janesch, L. V.
Publicado: (1928)

Cannot write session to /tmp/vufind_sessions/sess_jbj22unl21tdibfsltqjvcc8gh